MHRA Chief to step down in 2019
November 21, 2018Medical Communications, Research and Development MHRA, UK, brexit, pharma
The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …
Pfizer ask Senator Cindy Hyde-Smith to refund campaign donation after ‘public hanging’ comments
November 21, 2018Research and Development Pfizer, cindy hyde smith, donations, politics, public hanging
American pharma giant Pfizer have asked Mississippi Republican Senator Cindy Hyde-Smith to return campaign donations after the candidate was filmed …
Brexit referendum led to rise in antidepressant prescriptions
November 21, 2018Research and Development
The result of the Brexit referendum led to an increase in prescriptions for antidepressants, according to a study conducted by …
First-ever all-oral drug for sleeping sickness recommended for approval by EMA committee
November 20, 2018Manufacturing and Production, Sales and Marketing CHMP, EMA, Europe, Sanofi, fexinidazole, pharma, sleeping sickness
Sanofi’s fexinidazole, the first all-oral therapy for the treatment of human African trypanosomiasis (HAT), or sleeping sickness, has secured a …
Opioid dependency therapy price hiked 600% since 2014, Senate investigators find
November 20, 2018Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma
Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …
Merck KGaA and Pfizer’s Bavencio falls short in ovarian cancer
November 20, 2018Manufacturing and Production, Research and Development Bavencio, Cancer, Merck MGaA, Pfizer, ovarian cancer, pharma
Merck KGaA and Pfizer’s Bavencio (avelumab) has missed its primary endpoints in the treatment of platinum-resistant or -refractory ovarian cancer, …
Pfizer to resume price hiking in 2019; 41 drugs set to increase
November 20, 2018Manufacturing and Production, Sales and Marketing Pfizer, Trump, pharma, price hikes, price hiking, pricing
American pharma firm Pfizer has revealed plans to increase the prices of 41 medicines, the equivalent of 10% of its …
Eli Lilly’s Emgality cleared for treatment of migraine in Europe
November 20, 2018Manufacturing and Production, Sales and Marketing EU, Eli Lilly, Emgality, Europe, migraine, pharma
Eli Lilly’s Emgality (galcanezumab) has secured approval from the European Commission for the prophylaxis of migraine in adult patients who …
Novartis’ Promacta cleared by FDA for first-line use in severe aplastic anaemia
November 19, 2018Sales and Marketing FDA, Novartis, Promacta, Revolade, US, aplastic anaemia, pharma
Novartis has secured expanded approval from the FDA for Promacta (eltrombopag), allowing it to now be used in combination with …
Mundipharma name GSK veteran as new Senior Vice President & CFO
November 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president
The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …
Roche withdraws Tecentriq combo application in first-line renal cell carcinoma
November 19, 2018Sales and Marketing Cancer, Roche, avastin, pharma, renal cell carcinoma, tecentriq
The EMA has revealed that Roche has chosen to withdraw its marketing application for immunotherapy Tecentriq (atezolizumab) in combination with …
EU rules may be stifling Britain’s biotech industry
November 19, 2018Sales and Marketing EU, biotech, britain, funding, grants, industry
EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …
MSD’s Keytruda to treat melanoma in England on the Cancer Drugs Fund
November 19, 2018Sales and Marketing England, MSD, NHS, UK, keytruda, melanoma, pharma
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) will now be made available to patients in England via the Cancer Drugs Fund, it …
FDA trial may help to cut the number of dogs used in clinical trials
November 19, 2018Sales and Marketing Animal testing, animal activists, clinical trials, dogs, health, tests
A new study may help to significantly reduce the number of dogs that are used in clinical trials, according to …
Alector strengthens board with three appointments including Facebook CFO David Wehner
November 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Facebook’s Chief Financial Officer (CFO) David Wehner has joined the board of San Francisco-based biotech Alector, a company that hopes …
AstraZeneca’s Imfinzi immunotherapy combo fails to show benefit in lung cancer
November 16, 2018Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, lung cancer, pharma
AstraZeneca has revealed that its immunotherapy combo of Imfinzi (durvalumab) and tremelimumab failed to meet its primary endpoint in a …
Top Ten most popular articles on Pharmafile.com this week!
November 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10
The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
Boehringer signs $300 million deal with Epizyme over epigenetic cancer treatment
November 16, 2018Medical Communications Boehringer, Cancer, Epizyme, deal, oncology
German firm Boehringer Ingelheim and the Massachusetts-based biotech Epizyme have announced that they will collaborate on the development of novel, …
United Therapeutics buys Arena’s hypertension drug ralinepag in deal worth $1.2 billion
November 16, 2018Medical Communications Arena, PAH, United Therapeutics, deal sales, hypertension
US pharma firm United Therapeutics has agreed to by Arena Pharmaceuticals experimental pulmonary arterial hypertension (PAH) drug ralinepag in a …
Ipsen’s Cabometyx gains European approval in hepatocellular carcinoma
November 16, 2018Medical Communications, Sales and Marketing Cabometyx, carcinoma, ipsen, pharma. European Commission
Ipsen’s Cabometyx has received approval from the European Commission for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
